✦ LIBER ✦

The optimal duration of secondary thromboprophylaxis in patients with venous thromboembolism

✍ Scribed by Paul Alexander Kyrle

Publisher: Springer Vienna
Year: 2005
Tongue: German
Weight: 88 KB
Volume: 155
Category: Article
ISSN: 0043-5341
DOI: 10.1007/s10354-004-0135-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Venous thromboembolism in the patient wi

Venous thromboembolism in the patient with cancer : Focus on burden of disease and benefits of thromboprophylaxis

✍ Gary H. Lyman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 219 KB 👁 1 views

## Abstract Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients with cancer. The risk of VTE varies over the natural history of cancer, with the highest risk occurring during hospitalization and after disease recurrence. Patient and disease characteristics are

Risk of venous thromboembolism in patien

Risk of venous thromboembolism in patients undergoing cancer surgery and options for thromboprophylaxis

✍ David Bergqvist 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

Frequency of thromboprophylaxis and inci

Frequency of thromboprophylaxis and incidence of in-hospital venous thromboembolism in a cohort of emergency department patients

✍ Alan E. Jones; Zachary Fordham; Vasilios Yiannibas; Charles L. Johnson; Jeffrey 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 154 KB

Venous thromboembolism in the management

Venous thromboembolism in the management of patients with musculoskeletal tumor

✍ Takeshi Morii; Kazuo Mochizuki; Takashi Tajima; Takayuki Aoyagi; Kazuhiko Satomi 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 136 KB

Therapy of venous thromboembolism in pat

Therapy of venous thromboembolism in patients with brain metastases

✍ David Schiff; Lisa M. Deangelis 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB

Prophylactic recombinant erythropoietin

Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis

✍ Elias J. Anaissie; Elizabeth A. Coleman; Julia A. Goodwin; Robert L. Kennedy; Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 1 views

## Abstract ## BACKGROUND: Venous thromboembolism (VTE) is a significant but poorly understood complication in patients with newly diagnosed multiple myeloma (NDMM). As a result, most patients receive thromboprophylaxis with low molecular weight heparin (LMWH). The purpose of this retrospective st